Bortezomib Glenmark 2
As listed in the register: Bortezomib Glenmark 2,5 mg/ml oplossing voor injectie
2,5 mg/ml · oplossing voor injectie
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Bortezomib
- Made by
- Glenmark Arzneimittel GmbH
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States3 matching products
Bulgaria2 matching products
European UnionNo exact match for this strength and form
Spain11 matching products
- BORTEZOMIB ACCORD 2,5 mg/ml · solución inyectable
- BORTEZOMIB DR REDDYS 2,5 mg/ml · solución inyectable
- BORTEZOMIB EVER PHARMA 2.5 mg/ml · solución inyectable
- BORTEZOMIB FRESENIUS KABI 2.5 mg · polvo para solución inyectable
- BORTEZOMIB GLENMARK 2,5 mg/ml · solución inyectable
- BORTEZOMIB HOSPIRA 2,5 MG · polvo para solución inyectable
- BORTEZOMIB KOANAA 2,5 MG/ML · solución inyectable
- BORTEZOMIB QILU 2,5 mg/ml · solución inyectable
CanadaNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Glenmark Arzneimittel GmbH |
|---|---|
| Active substance | Bortezomib |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 2,5 mg/ml |
| Form | oplossing voor injectie |
| Classification | L01XG01 · Cancer treatments and immune-system medicines |
| Route | intraveneus gebruik, subcutaan gebruik |
| Dispensing (as stated by the register) | Uitsluitend recept |
| Name in the register | Bortezomib Glenmark 2,5 mg/ml oplossing voor injectie |
| RVG | 132426 |
Source: Geneesmiddeleninformatiebank · 2026-09-30 · not reviewed by a clinician
Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site. Reuse terms: CC0 1.0 (CBG website).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.